Respiratory Syncytial Virus Modelling for Immunisation_2nd Opinion
Delivery of a Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants in England/Wales/UK: second opinion model for Joint Committee on Immunisation and Vaccination (JCVI)
Buyer
Department of Health and Social Care (London)
Value
£29,000
Published
27 Jun 2023
Closes
31 Jan 2023
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Direct
Category
Services
Contract starts
1 Feb 2023
Contract ends
30 Jun 2023
CPV classifications
73000000
Research and development services and related consultancy services
Lots
Lot default Respiratory Syncytial Virus Modelling for Immunisation_2nd Opinion
£29,000
Delivery of a Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants in England/Wales/UK: second opinion model for Joint Committee on Immunisation and Vaccination (JCVI)
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
27 Jun 2023
Awarded contract notice on Contracts Finder
Award notice · Web page
C189086_RSV_2nd Opinion_SFContractv.3Redacted
Not provided
C189086_RSV_2nd Opinion_SFContractv.3Redacted
Contains public sector information licensed under the Open Government Licence v3.0.